Tag : CancerLinq

ABSTRACT: Strategies to overcome clinical, regulatory, and financial challenges in the implementation of personalized medicine.

This article highlights major developments over the last decade in personalized medicine in cancer. Emerging data from clinical studies demonstrate that the use of targeted agents in patients with targetable molecular aberrations improves clinical outcomes. Despite a surge of studies, however, significant gaps in knowledge remain, especially in identifying driver